G. Kuperstein

TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia

I. Yaniv, S. Avigad, R. Zaizov, 1999, Leukemia.

Could the 185 deIAG BRCA1 Mutation Be an Ancient Jewish Mutation?

B. Modan, E. Friedman, G. Rechavi, 1997, European journal of human genetics : EJHG.

Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

S. Narod, H. Lynch, E. Jack, 2001, American journal of human genetics.

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

L. Bégin, P. Chappuis, W. Foulkes, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

B. Rosen, L. Bradley, H. Risch, 2001, American journal of human genetics.

A genetic epidemiological study of carcinoma of the fallopian tube.

B. Rosen, S. Narod, J. McLaughlin, 2001, Gynecologic oncology.

Cancer incidence in a population of Jewish women at risk of ovarian cancer.

R. L. Baldwin, B. Karlan, S. Narod, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A rapid fluorescent multiplexed‐PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

W. Foulkes, S. Narod, P. Ghadirian, 2000, Clinical genetics.

A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.

S. Narod, E. Jack, G. Kuperstein, 2006, Genetic testing.